Craig Garrison

Most high-quality studies reported that impaired awareness in early-stage AD is cross-sectionally linked with fewer depressive symptoms and anxiety symptoms (correlation ranged from -0.3 to -0.7), but with more apathy. Conclusions High-quality studies suggested that in people with early AD, impaired awareness is related to fewer depressive and…[Read more]

Delayed senescence and total number of seeds per plant were related to higher expression of the peroxisomal antioxidant enzymes Cu/Zn superoxide dismutase (SOD3) and catalase (CAT2). These results evidence that high Zn-induced delayed senescence and improved reproductive fitness in Arabidopsis are related to an auxin-independent mechanism that…[Read more]

.

The study has identified the potential application of advanced biosensors as standardized clinical diagnostic tools for AD, evolving the way for new and efficient AD control with minimum economic and social burden. After clinical trial, nanobiosensors for measuring Aβ and Tau simultaneously possess innovative diagnosis of AD to provide…[Read more]

Hepatocellular carcinoma (HCC) is the typical inflammation-induced neoplasia. It often prospers where a chronic liver disease persists, thus leading a strong rationale for immune therapy. Several immune-based treatments, including immune checkpoint inhibitors (ICI), cytokines, adoptive cell transfer, and vaccines, have been tested in the treatment…[Read more]

Atezolizumab [anti-programmed death-ligand 1 (anti-PD-L1)] is well tolerated and efficacious in multiple cancers, but has not been previously evaluated in metastatic castration-resistant prostate cancer (mCRPC). This study examined the safety, efficacy, and biomarkers of atezolizumab monotherapy for mCRPC.

This phase Ia, open-label,…[Read more]